ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Scope & Guideline

Driving excellence in vascular research for a healthier tomorrow.

Introduction

Immerse yourself in the scholarly insights of ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1079-5642
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1990 to 2024
AbbreviationARTERIOSCL THROM VAS / Arterioscler. Thromb. Vasc. Biol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is dedicated to publishing high-quality research that advances the understanding of vascular biology, particularly in relation to cardiovascular diseases, thrombosis, and atherosclerosis. The journal emphasizes both basic and clinical research, fostering an interdisciplinary approach that incorporates molecular biology, genetics, and epidemiology.
  1. Vascular Biology and Pathophysiology:
    Research focused on the cellular and molecular mechanisms underlying vascular health and disease, including endothelial function, smooth muscle cell dynamics, and the role of vascular inflammation in atherogenesis.
  2. Thrombosis and Hemostasis:
    Investigations into the mechanisms of blood clot formation and resolution, including studies on platelets, coagulation factors, and the impact of various pathological conditions on thrombotic processes.
  3. Atherosclerosis Mechanisms:
    Studies elucidating the pathophysiology of atherosclerosis, including lipid metabolism, inflammatory processes, and the role of immune cells in plaque formation and stability.
  4. Genetic and Environmental Risk Factors:
    Exploration of genetic determinants and environmental influences on cardiovascular disease risk, with a focus on identifying novel biomarkers and therapeutic targets.
  5. Innovative Therapeutic Strategies:
    Research on new therapeutic approaches for cardiovascular diseases, including drug development, gene therapy, and the use of advanced biomaterials for vascular repair.
  6. Translational Research:
    Bridging basic science with clinical applications, aiming to translate findings from laboratory research into effective treatments and interventions for cardiovascular diseases.
The journal has shown a dynamic evolution in its focus areas, with emerging themes reflecting the latest advancements in vascular biology, technology, and clinical practice. These trends indicate a shift towards more integrated and innovative research methodologies.
  1. Precision Medicine Approaches:
    An increasing number of studies focus on personalized medicine, utilizing genetic and molecular profiling to tailor interventions for cardiovascular diseases, reflecting a broader trend in healthcare.
  2. Role of the Microbiome:
    Research exploring the influence of gut microbiota on cardiovascular health is gaining traction, with studies linking microbial metabolites to vascular inflammation and atherosclerosis.
  3. Immunometabolism in Cardiovascular Disease:
    The intersection of immune responses and metabolic processes in vascular disease is emerging as a critical area of research, highlighting the role of inflammation in atherosclerosis and thrombosis.
  4. Innovative Imaging and Biomarker Technologies:
    Advancements in imaging techniques and biomarker discovery are increasingly featured, enabling more precise monitoring of vascular health and disease progression.
  5. Novel Therapeutic Modalities:
    There is a rising interest in novel therapeutic strategies, including the use of nanoparticles, CRISPR technology, and RNA-based therapies, aimed at addressing vascular disease at a molecular level.
  6. Cellular Plasticity and Regenerative Medicine:
    Research on the plasticity of vascular cells and their potential for regeneration and repair is becoming more prominent, particularly in the context of stem cell therapies and tissue engineering.

Declining or Waning

While the journal continues to thrive in many areas, some themes have seen a decline in focus over recent years. These waning scopes may reflect shifts in research priorities or advancements in understanding that have led to saturation in particular topics.
  1. Traditional Risk Factor Studies:
    Research focusing solely on conventional cardiovascular risk factors (e.g., hypertension, cholesterol levels) has decreased as the field moves towards more complex, multifactorial models of disease.
  2. Basic Animal Models:
    There is a noticeable reduction in studies utilizing traditional animal models without incorporating modern techniques such as genetic manipulation or advanced imaging, as researchers seek more relevant and translationally applicable models.
  3. Single-Factor Interventions:
    Research that examines the effects of single interventions on vascular health, without considering the multifaceted interactions present in human health, is becoming less prevalent as the complexity of cardiovascular disease is better appreciated.
  4. Epidemiological Studies with Limited Scope:
    Epidemiological studies that focus narrowly on specific populations without integrating broader systemic factors are declining, as there is a push for more comprehensive approaches to understanding cardiovascular health across diverse populations.

Similar Journals

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Pioneering insights in cardiovascular science.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0363-6135Frequency: 12 issues/year

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, published by the American Physiological Society, is a premier journal dedicated to advancing the understanding of cardiovascular physiology. With an ISSN of 0363-6135 and an E-ISSN of 1522-1539, this esteemed journal has been a vital resource since its inception in 1977, and continues to publish cutting-edge research that shapes the fields of cardiology and physiology. Recognized as a Q1 journal in multiple categories, it ranks impressively within the top tier of its fields, including a notable 18th percentile rank in Physiology (medical). The journal’s impact factor and extensive reach in the academic community affirm its significance in promoting innovative studies and insights. While it does not offer open access options, the journal remains accessible through institutional subscriptions, making it an essential tool for researchers, professionals, and students alike, who are keen to stay abreast of the latest developments in heart and circulatory physiology. For further information, the journal is based in the United States at 6120 Executive Blvd, Suite 600, Rockville, MD 20852. As a cornerstone of cardiovascular research, it invites contributions that push the boundaries of knowledge and enhance clinical practice.

Current Opinion in Physiology

Advancing Insights in the Dynamic World of Physiology
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

Current Opinion in Physiology, published by Elsevier, is a leading journal dedicated to the dynamic field of physiology. With an E-ISSN of 2468-8673, this journal provides a platform for the latest insights and perspectives, reflecting the evolving landscape of physiological research. Operating from the United Kingdom, the journal holds a respectable impact factor and is ranked Q2 in both general physiology and medical physiology categories, highlighting its prominence among the global academic community. With Scopus rankings placing it in the 64th and 60th percentiles within its respective categories, Current Opinion in Physiology serves as an essential resource for researchers, professionals, and students eager to stay informed about innovative theories and emerging trends in physiology. The publication emphasizes high-quality reviews that summarize current knowledge and future directions, ensuring readers gain valuable insights applicable in both clinical and research settings.

International Journal of Angiology

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: THIEME MEDICAL PUBL INCISSN: 1061-1711Frequency: 4 issues/year

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

JOURNAL OF CARDIOVASCULAR SURGERY

Advancing the frontiers of cardiovascular surgery.
Publisher: EDIZIONI MINERVA MEDICAISSN: 0021-9509Frequency: 6 issues/year

JOURNAL OF CARDIOVASCULAR SURGERY, published by EDIZIONI MINERVA MEDICA, stands as a pivotal resource in the field of cardiovascular medicine and surgical practices. With a rich history dating back to 1960 and ongoing contributions scheduled until 2024, this esteemed journal provides a platform for the dissemination of innovative research in cardiology and surgical techniques. Registered under ISSN 0021-9509 and E-ISSN 1827-191X, it holds a commendable standing reflected in its Scopus rankings, placing it in the second quartile for both cardiology and cardiovascular medicine, as well as surgery. Despite not currently offering Open Access, the journal remains a vital source for practitioners and researchers alike, facilitating a deeper understanding of advancing methodologies and clinical practices in cardiovascular surgery. The journal is headquartered in Turin, Italy, and is committed to nurturing academic excellence within the community, making it an essential read for professionals, researchers, and students striving to enhance their knowledge and expertise in this critical field.

Vasa-European Journal of Vascular Medicine

Empowering Vascular Health with Cutting-Edge Scholarship
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 0301-1526Frequency: 6 issues/year

Vasa - European Journal of Vascular Medicine is a leading peer-reviewed journal dedicated to advancing the field of vascular medicine, published by HOGREFE AG in Switzerland. With a proud history dating back to 1972, this journal serves as a critical platform for researchers, clinicians, and healthcare professionals committed to enhancing knowledge and practice related to cardiovascular health and vascular disorders. Holding a notable Q2 ranking in the cardiology and cardiovascular medicine category, Vasa’s scholarly contributions reflect high-quality research and innovative insights that drive clinical applications. The journal provides essential access to original articles, reviews, and case studies, fostering a vibrant exchange of ideas within the vascular medicine community. Its Scopus rank of #159 out of 387 further underscores its impact, placing it confidently in the 59th percentile among its peers. Vasa is synonymous with rigorous academic standards and relevance, making it an invaluable resource for anyone seeking to stay at the forefront of vascular research and its clinical implications.

Acta Angiologica

Pioneering Innovations in Cardiovascular Medicine
Publisher: VIA MEDICAISSN: 1234-950XFrequency: 4 issues/year

Acta Angiologica, published by VIA MEDICA, is an Open Access journal dedicated to the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1995, this esteemed journal has provided a vital platform for the dissemination of cutting-edge research and innovative medical practices, especially pertinent to vascular health. Being indexed in Scopus, it holds a rank of #352 out of 387 in its category for 2023, positioning it in the 9th percentile among contemporaneous journals. The journal's commitment to scholarly excellence and accessibility is underscored by its embrace of open access publishing, allowing researchers, professionals, and students to engage with vital advancements in the field without financial barriers. With a converged timeline from 2005 to 2024, Acta Angiologica continues to play a crucial role in bridging gaps in cardiovascular knowledge, fostering collaboration across disciplines, and advancing the implementation of preventative and therapeutic strategies in vascular medicine. Located in Gdansk, Poland, the journal is poised to make significant contributions to the cardiovascular research landscape.

Journal of Atherosclerosis and Thrombosis

Bridging research and practice in cardiovascular health.
Publisher: JAPAN ATHEROSCLEROSIS SOCISSN: 1340-3478Frequency: 12 issues/year

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

Indian Journal of Vascular and Endovascular Surgery

Innovating Vascular Solutions for Better Outcomes
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-0820Frequency: 4 issues/year

The Indian Journal of Vascular and Endovascular Surgery, published by Wolters Kluwer Medknow Publications, serves as a premier platform dedicated to advancing research and clinical practices in the fields of vascular and endovascular surgery. With an E-ISSN of 2394-0999 and a commitment to open access since 2015, this journal provides invaluable insights to researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of knowledge. By focusing on innovative techniques, case studies, and systematic reviews, the journal plays a vital role in enhancing clinical outcomes and promoting evidence-based practices within the vascular community. Its commitment to high-quality research and accessibility positions it as an essential resource in the landscape of surgical literature, encouraging further exploration and collaboration within this critical area of healthcare.

ANGIOGENESIS

Connecting Researchers in the Vital Field of Angiogenesis
Publisher: SPRINGERISSN: 0969-6970Frequency: 4 issues/year

ANGIOGENESIS is a prestigious academic journal published by Springer, focusing on the vital field of angiogenesis research, a cornerstone in understanding tumor biology and tissue regeneration. Established in 1997 and continuously evolving, this journal has solidified its reputation, ranking in the Q1 category for Cancer Research, Clinical Biochemistry, and Physiology as of 2023. With an impressive impact factor, it serves as an essential platform for disseminating cutting-edge research findings, critical reviews, and novel methodologies. ANGIOGENESIS is indexed in high-impact databases and exhibits exceptional Scopus ranks—1st in Clinical Biochemistry, 6th in Physiology, and 14th in Cancer Research, underscoring its significant contribution to the scientific community. Although it does not currently offer open access options, it ensures that all articles maintain rigorous peer-review standards to meet the highest academic excellence. Researchers, professionals, and students alike will find ANGIOGENESIS to be an invaluable resource in advancing their knowledge and research in the intricate mechanisms of vascular biology.

Diabetes & Vascular Disease Research

Innovating solutions for diabetes-related vascular challenges.
Publisher: SAGE PUBLICATIONS LTDISSN: 1479-1641Frequency: 6 issues/year

Diabetes & Vascular Disease Research is a leading academic journal dedicated to advancing the understanding and treatment of cardiovascular and metabolic diseases, particularly diabetes. Published by SAGE Publications Ltd in the United Kingdom, this journal serves as a key resource for researchers, clinicians, and students seeking to explore the intricate relationship between diabetes and vascular health. With an impressive Impact Factor and ranked in the Q2 quartile in prominent categories such as Cardiology, Endocrinology, and Internal Medicine, the journal provides a platform for high-quality, peer-reviewed research. Covering a broad range of topics from pathophysiology to therapeutic innovations, Diabetes & Vascular Disease Research plays a vital role in shaping contemporary discourse in the field. With contributions from leading experts and a commitment to disseminating valuable findings, this journal is a must-read for anyone involved in the fight against vascular complications arising from diabetes.